CytoDyn signs deal to commercialize HIV drug
December 18, 2019 at 09:43 AM EST
Vyera agreed to pay upfront, regulatory and sales-based milestone payments of up to $87.5 million.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.